Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

BMC Psychiatry - United Kingdom
doi 10.1186/s12888-014-0341-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Metabolic Adverse Events Associated With Antipsychotic Polypharmacy Versus Monotherapy Among New Pediatric Users

Annals of Epidemiology and Public Health
2018English

PS1-37: Comparison of Antipsychotic Polypharmacy Trends Among Schizophrenia Patients Across Multiple Healthcare Systems

Clinical Medicine and Research
MedicineHome CareCommunity
2014English

Antipsychotic Treatment Patterns and Hospitalizations Among Adults With Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2008English

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Augmented Antipsychotic Therapy With Pantogam Active in Patients With Schizophrenia

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2015English

Antipsychotic Polypharmacy - Confusion Reigns

Psychiatrist
PsychiatryMental Health
2010English

Polypharmacy in Schizophrenia

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2020English

Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy